Serum SARS-CoV-2 antibodies in HIV-1-infected patients after inactivated vaccination and SARS-CoV-2 infection

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Immunogenicity and safety of an inactivated SARS‐CoV‐2 vaccine in people living with HIV: A cross‐sectional study2022 · 17 citations
2. 2Mucosal Immune Responses in People Living with HIV May Confer Protection from SARS-CoV-2 Infections After COVID-19 Vaccination2026
3. 3Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy2022 · 100 citations
4. 4Evaluation of the Effect of mRNA and Inactivated SARS-CoV-2 Vaccines on the Levels of Cytokines IL-2, IFN-γ, and Anti-RBD Spike SARS-CoV-2 Antibodies in People Living with HIV (PLHIV)2024
5. 5SARS-CoV-2-specific T-cell responses are induced in people living with human immunodeficiency virus after booster vaccination2024 · 5 citations